GPR55 as a New Cannabinoid Receptor: Still a Long Way to Prove It
- 21 March 2006
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 67 (3) , 252-253
- https://doi.org/10.1111/j.1747-0285.2006.00370.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In silico patent searching reveals a new cannabinoid receptorTrends in Pharmacological Sciences, 2006
- Evidence for novel cannabinoid receptorsPharmacology & Therapeutics, 2005
- Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716ABiochemical Pharmacology, 2003
- Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptorEuropean Journal of Pharmacology, 2003
- Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its functionFEBS Letters, 2002
- Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptorEuropean Journal of Pharmacology, 2000
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsProceedings of the National Academy of Sciences, 1999
- Angiotensin, LDL peroxidation and atherosclerosisLife Sciences, 1998
- Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 ReceptorJournal of Medicinal Chemistry, 1996